Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @gemini_thera
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @gemini_thera
-
We have enrolled the first patient in a Phase 1 study of GEM103 for dry AMD, enrolling patients with high-risk genetic variants in CFH. A big step in our mission to combine precision medicine and leading genetic insights in
#ophthalmology#dryAMD https://bit.ly/2FzuVP6Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re excited to announce the appointment of Jason Meyenburg, MBA, as Gemini’s Chief Executive Officer. Welcome, Jason! https://www.geminitherapeutics.com/gemini-therapeutics-announces-leadership-appointment/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, we're announcing the initiation of CLARITY, a disease registry and natural history study of subjects with dry AMD and high-risk genotypes. Learn more about CLARITY: https://www.geminitherapeutics.com/gemini-therapeutics-announces-the-initiation-of-clarity-a-disease-registry-and-natural-history-study-of-subjects-with-dry-amd-and-high-risk-genotypes/ …
#dryAMDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re pleased to announce that Gemini CEO James McLaughlin will present a company overview today at
@PiperJaffray’s 30thAnnual Healthcare Conference in New York City. Additional details here: https://www.geminitherapeutics.com/gemini-therapeutics-announces-presentation-at-the-piper-jaffray-30th-annual-healthcare-conference/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, we’re pleased to share that Gemini CEO James McLaughlin is in Chicago providing a company overview at the 2018
@aao_ophth Ophthalmology Innovation Summit. Read more here: https://www.geminitherapeutics.com/gemini-therapeutics-announces-presentation-at-the-ophthalmology-innovation-summit-at-the-2018-annual-meeting-of-the-american-academy-of-ophthalmology-oisaao/ …pic.twitter.com/zuALHfIt25
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Diverse expertise, singular vision: Our team, founders and SAB bridge the diverse specialties necessary to bring precision medicine to
#AMD. Learn more about our industry leaders: https://www.geminitherapeutics.com/who-we-are/ pic.twitter.com/usod62T7EG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're focused on solutions for patients--not a single technology. Learn more about our vision: https://www.geminitherapeutics.com/approach-progress/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There are two types of AMD: wet and dry. Do you know the difference? Learn more on
@macular_org website:https://www.macular.org/what-macular-degeneration …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dry AMD: “We believe that genetics plays a key role, and we’re spending a lot of time trying to understand these subpopulations,”- James McLaughlin, Gemini CEO. Read more about Gemini's unique approach in the
@BostonGlobe and the rising prevalence in#AMD.https://www.bostonglobe.com/metro/2018/09/09/hope-for-new-treatments-buoys-macular-degeneration-patients/TNBU9Nib9HWN5DwusJIMAK/story.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to all of the finalists last week at the
#XconomyAwards and to our CEO, James McLaughlin for winning the Young Innovator category!pic.twitter.com/TBjAWo5AzV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Gemini Therapeutics proslijedio/la je Tweet
Meet the Young Innovator
#XconomyAwards Finalists:@CKadoch/@DanaFarber/@DanaFarberNews,@hulissy/@careporthealth,@CMBS6/@SuonoBio, Luhan Yang/@egenesisbio, Kathleen McCarthy/@Skyhawk_Tx, James McLaughlin/@gemini_therahttps://www.xconomy.com/boston/2018/08/08/creating-companies-before-35-meet-the-young-innovator-award-finalists/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're not limited to a single approach. We have selected a range of technologies that are suited for each of our targets. https://www.geminitherapeutics.com/approach-progress/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are more than a drug development company: we are working to define and differentiate high-risk, genetically-defined subpopulations. By zeroing in the specific genetic risk factors, we can help a broad range of associated conditions. Learn more: https://www.geminitherapeutics.com/need-opportunity/ …pic.twitter.com/N66AulVBwT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our patient perspective keeps us inspired and commited to developing first-in class therapeutic agents for AMD and associated systemtic diseases. Keep up to date with our targets and projects: https://www.geminitherapeutics.com/approach-progress/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are partnered with leading academic institutions and corporate innovators, such as
@EdinburghUni, Sanquin and Stride Bio. Learn more about our partners: https://geminitherapeutics.com/approach-progress/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you looking to dive deep into retinal research? We're hiring an associate scientist, retina biology. Details here: https://www.geminitherapeutics.com/careers/
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How does
#AMD affect vision? Check out our vision simulator: https://www.geminitherapeutics.com/need-opportunity/ …pic.twitter.com/K4RqKykRxq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ICYMI: We welcomed two new members to our team and promoted our SVP for process development and manufacturing to CTO. Learn more about Claude, Sandra and Scott: https://www.geminitherapeutics.com/gemini-therapeutics-strengthens-senior-leadership-team-with-key-appointments-and-promotion/ …pic.twitter.com/HrWQLdGMce
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're seeking a Senior Clinical Program Manager who has a strong sense of initiative to lead trial implementation teams and manage clinical operations. Follow the link to learn more: https://www.geminitherapeutics.com/careers/
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Do you have experience in cell culture and biochemical assay techniques like Western blot, ELISA and PCR? We're seeking a talented scientist to join our retina biology group. Follow the link to learn more: https://www.geminitherapeutics.com/careers/
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.